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Abstract
Brucellosis is considered by the Food and Agricultural Organisation and the World Health Organisation as one of the most
widespread zoonoses in the world. It is a major veterinary public health challenge as animals are almost exclusively the
source of infection for people. It is often undiagnosed in both human patients and the animal sources and it is widely
acknowledged that the epidemiology of brucellosis in humans and animals is poorly understood, particularly in sub-Saharan
Africa. It is therefore important to develop better diagnostic tools in order to improve our understanding of the
epidemiology and also for use in the field for disease control and eradication. As with any new diagnostic test, it is essential
that it is validated in as many populations as possible in order to characterise its performance and improve the
interpretation of its results. This paper describes a comparison between a new lateral flow assasy (LFA) for bovine brucellosis
and the widely used cELISA in a no gold standard analysis to estimate test performance in this West African cattle
population. A Bayesian formulation of the Hui-Walter latent class model incorporated previous studies’ data on sensitivity
and specificity of the cELISA. The results indicate that the new LFA is very sensitive (,87%) and highly specific (,97%). The
analysis also suggests that the current cut-off of the cELSIA may not be optimal for this cattle population but alternative cut-
offs did not significantly change the estimates of the LFA. This study demonstrates the potential usefulness of this simple to
use test in field based surveillance and control which could be easily adopted for use in developing countries with only
basic laboratory facilities.
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Introduction
Brucellosis is considered by the Food and Agricultural
Organisation and the World Health Organisation as one of
the most widespread zoonosis in the world. Brucellosis in
humans (mainly due to Brucella melitensis and B. abortus)
produces an acute febrile disease that may progress to a
chronic form. Brucellosis in animals is a sub-acute or chronic
disease affecting a range of domestic and wildlife species [1].
Mortality rates may be around 5% higher in calves from
seropositive cows [2], with high morbidity rates in adults.
Brucellosis it is the leading cause of contagious abortion in
livestock. The most important species are B. abortus, B melitensis
and B. suis causing abortions, premature births and retained
placentae in livestock [3]. Risk factors for human cases often
include consumption of fresh dairy products that have not been
pasteurized, contact with infected animals or abortive material,
handling animals products [4]. Animals are almost exclusively
the source of infection for people and therefore any attempts at
reducing the human disease burden is dependent on identifying
the infected animal source.
Sub-Saharan Africa (SSA) has the world’s fastest growing
population where livestock rearing is still the principal economic
activity supporting livelihoods in the desert, arid grasslands and
savannahs where the harsh environment is unsuitable for other
forms of agriculture. This disease is considered the most important
veterinary public health issue in the region and reducing the
burden of infection in livestock through testing and removal of
seropositive individual animals should reduce the risk of new
human cases, thereby having a major public health impact.
However, funding for control programmes has declined in the last
20 years [1] while at the same time there is increasing small-holder
dairying and increasing cattle densities in the region. Schelling et
al. [5] have estimated the human prevalence of seropositivity in
neighbouring Chad to be 3.8%, highlighting the enormous public
health issue that is largely being ignored.
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a rapid and simple point-of-care test, the Brucella IgM/IgG
immunochromatographic lateral flow assay for the serodiagnosis
of human brucellosis [6,7]. This has recently been adapted for
testing cattle sera [8] and is hereafter referred to as the lateral flow
assay (LFA). The LFA is a simplified ELISA for the qualitative
detection of antigen specific antibodies in serum or whole blood
samples. The assay is based on the binding of specific antibodies to
antigen immobilized on a test strip. Bound antibodies are
visualized using a secondary antibody conjugated to colloidal gold
particles. Binding of the conjugate at the test zone of the assay
device is visible by the unaided eye and results may be read within
10 minutes. Application of the assay requires neither specific
expertise, equipment or electricity, and tests may be kept in stock
without the need for refrigeration.
This paper describes a comparison between this new LFA for
bovine brucellosis and the O.I.E. reference cELISA in a no gold
standard analysis. The test’s sensitivity and specificity were
estimated for a West African Bos indicus cattle population and
the implication of using the test are discussed.
Methods
Study Population
The cattle were sampled in the year 2000 as part of a population
based study and the design has been described previously [9]. In
brief, the study area was the five administrative Divisions, Vina,
Mbere, Djerem, Mayo Banyo and Faro Deo of the 64,000 km
2
Adamawa Province of Cameroon. A two-stage random sampling
of herds was carried out based on a sample frame of the 13,006
herds registered for rinderpest vaccination in the Province. Within
selected herds 5 juvenile animals (6–24 months old) and 5 adult
animals (.24 months old) were randomly selected. Jugular blood
samples were collected into 10 ml plain vacutainers which were
then centrifuged at 1,100 g for 10 minutes in the field using a
‘Mobilespin’ 12V field centrifuge (Vulcon Technologies) or a hand
crank centrifuge (OFI Testing Equipment, Inc.). Approximately
3.5 ml of serum was aliquoted into 261.8 ml cryovials (Nunc).
The sera were stored at 4uC in a portable gas fridge until they
could be frozen and stored at 220uC. The sera were carried to the
UK on dry ice and stored at 220uC at the FMDV World
Reference Laboratory, Pirbright, UK. The herds were presumed
to be unvaccinated because no government licenses have been
issued to import vaccines into the country and Brucella was not
one of the routine vaccines used by the government veterinary
services at the time of the sample collection. The cELISA was
performed at the Institute for Animal Health (IAH), Pirbright by
staff from the Veterinary Laboratory Agency (VLA), Weybridge in
2003 and the LFA was carried out in 2007. Each testing round was
done blind using the same serum samples at IAH.
cELISA
The cELISA for Brucella diagnostic kits is based on detection of
the lipopolysaccharide (LPS) antigen of smooth Brucella strains.
The immunodominant epitope of the LPS is the O-chain which is
a homopolymer of 1,2-linked N-acylated 4-amino-4, 6-dideoxy-a-
D-mannopyranosyl residues [10]. The cELISA was provided and
performed by VLA staff according to the O.I.E. Manual of
Standards for Diagnostic Tests and Vaccines [11] using the 16 M
Melitensis strain as antigen and OPD as the chromogen, stopped
with Citric acid. The optical density (OD) was read at 450 nm and
the percentage OD of the conjugate (% OD) were calculated as
the average OD of the paired sample wells divided by the average
OD of the four conjugate wells on the plate. The cELISA used a
monoclonal antibody specific to the O-chain polysaccharide
portion of the Bucella LPS [12]. The standard %OD cut-off of
70% was used initially for interpretation of results but 60% and
50% cut-offs were also explored in the latent class analysis.
Brucella Lateral Flow Assay (LFA)
The Brucella LFA device for the serodiagnosis of bovine
brucellosis consists of a porous nitrocellulose detection strip
flanked at one end by a reagent pad and at the other end by an
absorption pad. A sample application pad flanks the reagent pad
in turn. The composite strip is contained in a plastic assay device
with a round sample well positioned above the sample application
pad and a test result window positioned above the detection zone
of the strip. The detection zone contains two distinct lines, a test
line and a control line. The test line was manufactured by spraying
Brucella-LPS antigen onto the nitrocellulose strip and the control
line by spraying bovine immunoglobulin G (IgG) antibodies. Test
and control lines were sprayed using a BioDot Quanti 2000 BioJet.
As Brucella-specific antigen a LPS extract from a solid culture of
Brucella abortus strain 1119-3 was used [6]. A detection reagent was
prepared by conjugating affinity purified antibodies against cattle
Ig (H+L) antibodies to 40 nm colloidal gold particles and this
conjugates were sprayed onto the conjugate pad of the composite
strip using the AirJet of the BioDot Quanti 2000 machine. Tests
are performed by the addition of 5 ml serum to the sample pad of
the assay device followed by the addition of 130 ml sterile running
fluid consisting of phosphate-buffered saline, pH 7.6, containing
1.67% bovine serum albumin and 3% Tween 20. Test results were
read after 10 min by visual inspection for staining of the antigen
and control lines. Tests were scored negative when no staining was
observed at the test line and scored positive when the test line
stains. The control line should stain in all cases. The test line may
stain at different intensities, and positive results may be
subjectively rated 1+ when staining is weak, 2+ when staining is
moderately strong, 3+ when staining is strong, and 4+ when
staining is very strong. Devices sealed in a humidity resistant foil
and containing silica may be stored at 4–27uC without loss of
activity. The stain of exposed tests is stable after drying.
Statistical Analysis
Hui & Walter [13] introduced a latent class approach to the
evaluation of diagnostic tests in absence of a ‘‘gold-standard’’. The
Hui-Walter paradigm requires two (or more) tests evaluated in two
(or more) populations. This model assumes that: (i) the prevalence
of the disease is different within each population; (ii) the tests have
the same properties across populations; (iii) and the tests are
conditionally independent given the disease status.
The Bayesian version of the Hui-Walter model [14] assumes
that for the ith subpopulation the counts (Oi) of the different
combinations of test results, +/+, +/2, 2/+ and 2/2 for the two
tests, follow a multinomial distribution:
Oij Sej,Spj,pi*Multinominal Pri,n i ðÞ
for i~1,2,...,S and j~1,2,...,T
where S is the number of subpopulations, T is the number of tests
and Pri is a vector of probabilities of observing the individual
combinations of test results. Conditioning on the (latent) disease
status, these probabilities can be specified using the Sej and Spj of
the tests and the prevalence (pi) of the subpopulations. As an
example, for two tests the probability of observing both tests
LFA & cELISA for Brucellosis
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Pr T1z,T 2z ðÞ ~Se1 Se2 piz 1{Sp1 ðÞ 1{Sp2 ðÞ 1{pi ðÞ
The other three probabilities for the three test scenarios may be
similarly derived.
In a Bayesian analysis all parameters are expressed as random
variables. Hence, prior distributions for the test properties and the
prevalence within the subpopulations must be specified. For those
parameters where no information was available the distributions
were modelled using uninformative, uniform priors on the interval
between zero and one:
Se1*Unif 0,1 ðÞ ; Se2*Unif 0,1 ðÞ ;
Sp1*Unif 0,1 ðÞ ; Sp2*Unif 0,1 ðÞ
However, there have been a number of recent publications
where estimates were given for the Se and Sp of the cELISA.
Table 1 gives the references and the sample sizes of the studies
involved. These were then incorporated into the Bayesian
framework as priors for the Se and Sp of the cELISA (see
appendix for coding of full model) to inform posterior estimates.
If the two tests can not be reasonably assumed to be
independent then the Hui and Walter model must be extended
to account for the covariance structure between the two tests
[15,16] as below:
Pr T1z,T 2z ðÞ ~
Se1 Se2 ðÞ zcovDp ðÞ piz 1{Sp1 ðÞ 1{Sp2 ðÞ ðÞ zcovDn ðÞ 1{pi ðÞ
Pr T1z,T 2{ ðÞ ~
Se1 ðÞ 1{Se2 ðÞ ðÞ {covDp ðÞ piz 1{Sp1 ðÞ Sp2 ðÞ {covDn ðÞ 1{pi ðÞ
Pr T1{,T 2z ðÞ ~
1{Se1 ðÞ Se2 ðÞ {covDpÞpiz Sp1 1{Sp2 ðÞ ðÞ {covDn ðÞ 1{pi ðÞ
Pr T1{,T 2{ ðÞ ~
1{Se1 ðÞ 1{Se2 ðÞ zcovDp ðÞ piz Sp1Sp2 ðÞ zcovDn ðÞ 1{pi ðÞ
The covDp and the covDn are the covariances between the two
tests when the animal is diseased and when it is not diseased
respectively. The covariance between the test outcomes for
infected subpopulations satisfies (Se121)(12Se2)#covDp#(min
[Se1,Se2]2(Se1Se2)) and for the non-infected subpopulation,
(Sp121)(12Sp2)#covDp#(min[Sp1,Sp2]2(Sp1Sp2)) [17]. There-
fore, for instance, a uniform ((Se121)(12Se2), (min[Se1,Se2]2
(Se1Se2))) prior distribution can be used for covDp.
The model was implemented in WinBUGS [18]. For this
analysis, the first 200,000 iterations were discarded as a burn-in and
the following 300,000 iterations were kept for posterior inference.
Convergence of the chain after the initial burn-in was assessed by
visual inspectionof the time-series plots for the parameters as well as
Gelman-Rubin diagnostic plots using three sample chains with
dispersed starting values [19]. The models were compared using the
Deviance Information Criteria (DIC) [20].
The positive predicted values (PPV) were calculated for a
number of test parameter combinations over a range of lower
potential seroprevalences using the following formula:
PPV~
Se|p
Se|p ðÞ z 1{Sp ðÞ | 1{p ðÞ
Where Se is the estimated test sensitivity, Sp is the estimated test
specificity, p is the true seroprevalence in the population.
Results
A total of 1,375 serum samples from 146 herds from the
Adamawa Province of Cameroon were screened with both tests.
The %OD for the cELISA shown in Figure 1 clearly demonstrates
a bimodal distribution of the values across the sampled population.
The plot suggests that there may be a better %OD cut-off of 50%
for the cELISA in this African cattle population which we have
explored later in the analysis.
Model 1: Informative cELISA priors with conditional
dependence and a %OD cut-off of 70%
The first model used the standard %OD of 70% as the cut-off
and all the prior information available from previous studies of the
cELISA (Table 1) while the LFA was given non-informative
beta(1,1) priors. The Se, Sp, and p estimates from the model are
given in Table 2 and the full posterior distributions plotted in
Figure 2. The distributions show that the prior estimates of Se and
Sp for the cELISA, taken from previous studies, dominate the
information from the data. The estimate of the Se of the LFA from
this model has a mean of 0.869 with a very high Sp of 0.970. The
model showed good mixing and convergence a DIC of 53.95. The
animal-level prevalences were all very low at ,0.01 for four of the
five administrative Divisions and 0.02 in the highest in Faro et
Deo. The cross correlations between the parameters in model 1
Table 1. Estimates of Se and Sp and sample sizes used from literature search.
Paper Cut-off Se Sp N Se R Se N Sp R Sp
Fosgate et al. (2003)[36] 30 PI 0.839 0.926 63 53 323 299
Gall et al. (1998) [37] 26 PI 0.975 0.983 1857 1810 2613 2569
McGiven et al. (2003) [28] 70 %OD 0.952 0.997 146 139 1440 1436
Neilson et al. (1995) [38] 30 PI 1 0.997 636 636 1446 1442
Nielson et al. (1996) [39] Not given 0.986 0.977 654 645 1508 1473
Stack et al (1999) [12] 60 %OD 0.979 1 147 144 640 640
Se=sensitivity; Sp=specificity; N Se=number in sample for Se estimation; R Se=number test positive; N Sp=number in sample for Sp estimation; R Sp=number test
negative; PI=percentage inhibition; %OD=percentage of the OD of the conjugate.
doi:10.1371/journal.pone.0005221.t001
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correlated with the covDp and the Sp of both tests is quite strongly
negatively correlated with the covDn.
Model 2 Informative priors with %OD of 70% as cut-off
and assuming conditional independence
If the assumption of conditional independence is used (i.e.
covariances are fixed at zero) the parameter estimates change only
slightly but the DIC for this model increased to 82.02 suggesting a
much poorer model fit and a lower predictive ability, so this model
was not considered further.
Model 3 Conditional dependence with %OD of 60% and
50% as the cut-off for the cELSIA with non-informative
priors
From Figure 1 the cut-off for the cELISA could reasonably be
adjusted to 60% or 50% OD. However, there is little or no
information on how the tests perform at these cut-offs and so we
attempted to fit a model using non-informative priors Unif(0,1) for
both tests’ Se and Sp and allowing conditional dependence.
However, in spite of being a large population sample, there was
insufficient information in the data to estimate all 11 parameters in
the model with any certainty. The model was explored further by
adjusting the priors for the cELISA as it was argued that even with
the shift in cut-off it was reasonable to believe the SecELISA and
SpcELSIA to be high, although probably the SecELISA might have
dropped. Beta(5,2) and Beta(2,1) priors were tried for the cELISA
and LFA parameters respectively but the credible intervals were
still very large because there was insufficient information from the
data to identify the tests’ parameters due to the low prevalence of
disease. For example at 50% OD cut-off the 95% BCI for the
SeLFA ranged from 0.008 to 0.926 and the 95% BCI for the p[1]
from 0.004 to 0.931. In order to try and improve the certainty of
the estimates we simplified the model and dropped the conditional
dependence component and therefore 2 parameters but in spite of
convergence of the chains the credible intervals were still
extremely large. These were not explored any further as there
was no further information available to set priors for the cELSIA
at these cut-offs.
In figure 4 the PPV of a positive test result for the LFA is plotted
against the prevalence of infection for various combinations of test
Se and Sp, and the PPV for the LFA at each of these combinations
for the observed prevalence of brucellosis in the cattle population
in Adamawa Province is indicated.
Discussion
An important component of any disease control effort is the
ability to identify infected or infectious animals and treat or
remove them from the population. In the case of brucellosis,
identifying infected animals and removing from the herd is key to
the control of the disease in both the livestock and the human
populations. Although some diagnostic or screening tests are
referred to as the ‘‘gold standard’’, there are in fact few perfect
diagnostic tests and there is always a compromise between
performance and cost. For example, many screening programmes
use tests with less than perfect Sp if this gives a high Se and then
use a more specific test to confirm any positive animals.
The best estimates using all the information available suggest
that the LFA is a sensitive and highly specific test. This means that
at the low seroprevalence of 1–2% found in this region of West
Africa, the PPV of a positive test result for the LFA (assuming a Se
of ,87% and a Sp of ,97%) is approximately 50%. However, the
PPV markedly increases as the Sp increases or if the prevalence of
disease is higher. The high Sp of the LFA ensures the prognostic
value of a positive LFA test results is still very good when testing
animals in areas where the prevalence of brucellosis is relatively
low. Its ease of use makes it a very attractive screening tool for use
in bovines and removes the need for laboratory facilities and plate
readers.
Model 1 gives very low seroprevalence estimates for cattle in the
Adamawa in 2000. The seroprevalence appears to be between
0.5% (95% BCI: 0–1.6%) in Mayo Banyo and 2.1% (95% BCI:
0.1–5.5%) in Faro et Deo. This contrasts with previous estimates
in the Lake Chad region where in the 1980s much higher
seroprevalences of ,30% were reported for Cameroon and 19.6%
Figure 1. Histogram of cELISA percentage OD of the conjugate.
Histogram of the distribution of OD values expressed as the percentage
OD of the conjugate for 1,375 cattle from Adamawa Province
Cameroon. The standard cut-off of ,70% OD and the ,60% OD for a
positive test result are also plotted as grey vertical lines.
doi:10.1371/journal.pone.0005221.g001
Table 2. Parameter estimates for Model 1 with 95% Bayesian
credibility interval (BCI) using prior estimates for the cELISA
from literature and conditional dependence between tests at
a 70% OD cut-off for the cELISA. DIC for model 1 was 53.95.
Parameter Mean 2.5% BCI 97.5% BCI
Se (LFA) 0.869 0.503 0.996
Sp(LFA) 0.970 0.962 0.977
Se(cELSIA) 0.978 0.973 0.983
Sp(cELISA) 0.987 0.984 0.989
covDn 0.012 0.009 0.015
covDp 0.008 20.005 0.020
P(Vina) 0.009 0.001 0.024
P(Mbere) 0.009 0.000 0.028
P(Djerem) 0.006 0.000 0.021
P(Mayo Banyo) 0.005 0.000 0.016
P(Faro et Deo) 0.021 0.001 0.055
doi:10.1371/journal.pone.0005221.t002
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recent estimates of between 5 and 10% reported from an abattoir
survey in Western Province Cameroon in 2003 [22] and 7% in
neighbouring Chad in 2000 [5] although these were different
populations owned by different ethnic groups with different
husbandry approaches. However, it is not the focus of this paper
to enter a detailed discussion of brucellosis in Cameroon, rather to
reflect on the utility of this new test.
The principal methods of diagnosis of bovine brucellosis are
culture, the complement fixation test, serum agglutination test,
Rose-Bengal test (RBT), indirect enzyme-linked immunosorbent
assay and more recently the competitive ELISA (cELISA) and the
fluorescent polarisation assay. However, identification of the
organism is complex and time consuming and not suitable for
large scale screening exercises. Guidelines set by the O.I.E.
describe methods and diagnostic thresholds for each of these tests
[23]. In the African setting the rose Bengal test (RBT) is widely
used for its simplicity and field suitability, for example in Ethiopia
and Uganda [24,25]. The sensitivity and specificity of these tests in
the field in Africa is not well described. Recent studies of the
various tests has suggested that the RBT may have a Se between
80 and 90% and a Sp around 86% [26,27]. Estimates for the Se of
the cELISA are in the high 90s while the Sp appear to range more
widely from 60–99.7% [26–28]. Though this study did not
compare the LFA directly with the RBT, our results suggest that
the LFA should be as sensitive as the RBT but have a much higher
specificity. This has the advantage that, except in areas with very
low prevalence, the PPV will be very good. The LFA is probably
not ideal for large scale screening but could provide a very useful
tool in transition countries to identify animals in small holder herds
that are infected so that they can be removed or their milk rejected
or for providing public health advice to farmers following
abortions in their herds.
Most brucellosis serological tests depend on the detection of
antibodies to smooth Brucella LPS (SLPS). These tests are typically
developed using B. abortus SLPS given the focus on its importance
in the serodiagnosis of humans. Even so, different Brucella species
with the same LPS form will cross react as it is very similar [29]. B.
melitensis and B. suis contain SLPS while B. ovis and B. canis have
rough LPS [30]. There has been some suggestion [31–33] that
there can be problems with cross-reactivity to Yersinia pestis where it
is present but there was no way to explore this here. LFAs have
also been developed for testing other livestock species for
brucellosis and the use of these LFAs could be equally attractive
[8]. In spite of this limitation all the tests based on this antigen
have proved useful in the past and this should not detract from the
potential of this new test with its higher Se and Sp. The serum
used here was originally collected in 2000 and was tested for
Brucella antibodies in 2003 and 2007 requiring thawing and
freezing. There is not a large literature on the effects of freezing
and thaw on antibodies but reports in both the veterinary and
human medical literature suggest that they are very robust and
that there is no evidence for a significant decline in antibody levels
in samples following repeated freeze/thaw cycles [34,35]
Figure 2. Posterior distributions of test parameters for the LFA from model 1. Posterior distributions from Model 1 using prior estimates for
the cELISA from literature and conditional dependence between tests at a %OD cut-off of 70% for the cELISA. Se[1]=Se of the cELISA; Se[2]=Se of
the LFA; Sp[1]=Sp of the cELISA; Sp[2]=Sp of the LFA; p[1]=p for Vina; p[2]=p for Mbere; p[3]=p for Djerem; p[4]=p for Mayo Banyo; p[5]=p for
Faro et Deo.
doi:10.1371/journal.pone.0005221.g002
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formulation of the Hui and Walter model provides the most
reliable estimates of diagnostic Se and Sp as well as an unbiased
estimate of true prevalence (though this was not the particular
focus of this analysis). Using the comparison with the cELISA at a
cut-off of 70% and adjusting for conditional dependence and prior
estimates of Se and Sp for the cELISA gives the best model and
estimates of 87% (95% BCI: 50.3–99.6%) Se and 97% (95% BCI:
96.2–97.7) Sp for the LFA reflecting the much higher certainty in
the Sp estimates than those of Se. The distribution of %OD values
suggests that a lower cut-off of 60% or even 50% might be
appropriate for the cELISA. Although this was explored, without
good estimates of the cELSIA Se and Sp at these cut-offs, it was
not possible to get estimates with useful credibility intervals for the
Se and Sp of the LFA. These results support previous studies and
suggest that the LFA may provide a very useful public health tool
for control of brucellosis.
Good quality data on the impact of brucellosis in sub-Saharan
Africa is still lacking. Brucellosis in cattle is prevalent and
widespread in sub-Saharan Africa and the disease is endemic in
most pastoral systems. Because culling and other methods to
control brucellosis are not widely used in sub-Saharan Africa,
long-term chronic infections could be common and these provide
a steady supply of infectious organisms. While animals with
chronic disease may be difficult to detect by serology, the presence
of seropositive animals provide a good indication of ongoing
transmission. Further studies looking for presence of brucellosis in
humans, confirming the presence of brucellosis in livestock by
culture and correlating seropositivity in herds with disease
manifestations such as abortions are required to determine the
impact of the disease [1].
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